Clinical decision support alerts for Valproate medicines

Owned by norris.orighoye1 (Unlicensed)
Last updated: 21-04-2023 by Jenna Bennett (Unlicensed)
ID

RM116

Version1.1.0
TypeRoadmap Item


Title

Clinical decision support alerts for Valproate medicines

Description

Modify age range of females for issuing warnings to ensure contraception is provided

Date Added

 

Standards and Capabilities

Prescribing - Standard 

Change Route

Managed Capacity - Minor/Patch uplifts

Change Type

New

Status

Closed

Publication Date 
Effective Date

 

Incentives / Funding

No

Incentive Dates

N/A


Background

For prescribing of High risk drug Sodium Valproate to female, there must be a warning to ensure contraception is provided. This applies to females of an age range that could become pregnant. The current age range of 13 years to 49 years inclusive is not compatible with current best practice. The age range advised nationally has been changed to 12 years through to 55 years inclusive.


Outline Plan

There should be appropriate assurance that change is implemented correctly.


Summary of Change

Modify the current age range of females that could become pregnant from 13 years to 49 years inclusive to 12 years to 55 years inclusive.

Requirements GP-07.1-013A andGP-07.20-08 would be uplifted in the Prescribing - Standard to reflect the new age range of 12 years through to 55 years inclusive. 

Requirements

Epic Mapping
Requirement ID
Requirement Text
Level
C14E9GP-07.20-08

Sodium Valproate Reporting

Report using the following criteria on the number of people who are currently prescribed Sodium Valproate:

Gender:

  • Female

Age:

  • 12 years or above and less than 50 years old
  • 12 years to 55 years inclusive. 
MUST
C14E15

GP-07.1-013A

Configurable warnings on Prescribing

A Practice Configurable warning for specific Prescribable items which can be used in conjunction with other criteria, but not limited to:

  • Gender
  • Age

For example, this can be used to display a warning when prescribing Sodium Valproate to females aged 12 or over and less than 50 years old. 12 years to 55 years inclusive. 

MAY


Full Specification

For females about to be prescribed Valproate, provide warning message if the Patients age is between 12th birthday and end of 55th year.

The following version of existing Standard impacted by this roadmap item have now been published.

  • (Archived) Prescribing - Standard v1.1.0


Assurance Approach

Confirm by email that change has been tested and provide date rollout commenced and expected completion date.